SARS-CoV-2 serology testing in the setting of vaccination
22 Jan 2021

Ensuring the effectiveness of COVID-19 vaccines will play a key role in promoting public health, including prioritization of the more vulnerable populations if vaccine is limited and assessing sufficient and durable protection, as well as building and promoting public confidence.

In this SelectScience webinar, virologist Dr. Angela Rasmussen will detail how serology testing is necessary to understand whether vaccination results in seroconversion and a sustained response in each person, especially for high-risk/high-exposure people, describe how clinical serology testing is relatively low cost and high throughput, with fast turnaround and broad population access, and explain why this testing will be necessary to confirm seroconversion and a sustained response of neutralizing antibody.

Key Learning Objectives

  • Learn how serology testing can help prioritize vaccine resources and inform long-term vaccination strategy
  • Understand how serology testing can be used to establish a threshold for protection or immunity
  • Know how to use serology to confirm an initial neutralizing antibody response shortly after vaccination and track antibody levels over time to access duration of protection

Who Should Attend?

Clinicians, laboratorians and other healthcare professionals

Certificate of attendance

All webinar participants can request a certificate of attendance, including a learning outcomes summary for continuing education purposes.

CEU credits

Attendees of this webinar are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC.

Siemens Healthineers